tiprankstipranks
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market
NATCOPHARM
NATCO Pharma Limited
RESEARCH TOOLSreports

NATCO Pharma Limited (NATCOPHARM) Ratios

16 Followers

NATCO Pharma Limited Ratios

IN:NATCOPHARM's free cash flow for Q2 2026 was ₹0.88. For the 2026 fiscal year, IN:NATCOPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.46. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 4.10 5.59 4.14 4.39 3.52
Quick Ratio
 3.62 4.77 3.32 3.21 2.30
Cash Ratio
 0.06 2.31 0.07 0.19 0.16
Solvency Ratio
 0.99 2.03 1.49 -0.25 0.36
Operating Cash Flow Ratio
 0.70 1.80 1.25 1.24 0.07
Short-Term Operating Cash Flow Coverage
 4.71 6.21 3.20 4.87 0.11
Net Current Asset Value
₹ 51.91B₹ 42.52B₹ 29.70B₹ 64.80B₹ 16.52B
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.03 0.06 0.03 0.08
Debt-to-Equity Ratio
 0.03 0.04 0.07 0.04 0.10
Debt-to-Capital Ratio
 0.03 0.04 0.06 0.03 0.09
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.21 1.13 1.18 1.16 1.20
Debt Service Coverage Ratio
 5.96 5.96 3.69 4.34 0.52
Interest Coverage Ratio
 50.56 163.95 135.22 102.87 39.15
Debt to Market Cap
 0.01 0.02 0.02 0.02 0.03
Interest Debt Per Share
 16.57 16.62 22.58 10.44 24.65
Net Debt to EBITDA
 0.08 -0.88 0.18 0.05 1.23
Profitability Margins
Gross Profit Margin
81.97%83.59%81.29%75.84%69.97%
EBIT Margin
40.06%44.36%39.25%29.90%6.34%
EBITDA Margin
44.46%48.38%43.74%35.70%13.36%
Operating Profit Margin
39.89%67.70%64.87%55.07%35.61%
Pretax Profit Margin
40.60%51.70%41.82%31.82%10.39%
Net Profit Margin
34.13%42.54%34.69%26.41%8.73%
Continuous Operations Profit Margin
33.85%42.50%34.69%26.41%8.73%
Net Income Per EBT
84.05%82.28%82.96%82.99%84.08%
EBT Per EBIT
101.78%76.37%64.46%57.78%29.18%
Return on Assets (ROA)
14.93%21.85%20.10%12.64%3.33%
Return on Equity (ROE)
20.08%24.79%23.72%14.68%3.99%
Return on Capital Employed (ROCE)
20.85%39.03%43.75%29.99%15.75%
Return on Invested Capital (ROIC)
16.89%30.97%34.11%24.04%12.08%
Return on Tangible Assets
15.31%22.54%20.68%13.08%3.42%
Earnings Yield
7.88%13.08%7.94%6.95%1.23%
Efficiency Ratios
Receivables Turnover
 2.64 3.53 3.15 3.00 2.84
Payables Turnover
 1.60 2.65 3.18 2.48 3.61
Inventory Turnover
 1.01 0.95 0.95 0.81 0.68
Fixed Asset Turnover
 1.69 1.67 1.64 1.18 0.84
Asset Turnover
 0.44 0.51 0.58 0.48 0.38
Working Capital Turnover Ratio
 1.73 1.20 1.49 1.32 1.08
Cash Conversion Cycle
 273.84 349.77 386.85 425.51 565.81
Days of Sales Outstanding
 138.32 103.44 115.69 121.47 128.56
Days of Inventory Outstanding
 362.96 384.27 385.96 451.17 538.29
Days of Payables Outstanding
 227.45 137.94 114.81 147.14 101.04
Operating Cycle
 501.28 487.71 501.66 572.65 666.85
Cash Flow Ratios
Operating Cash Flow Per Share
 66.48 94.73 67.50 46.51 2.55
Free Cash Flow Per Share
 56.41 79.72 48.59 35.25 -10.76
CapEx Per Share
 10.07 22.39 18.91 11.26 13.31
Free Cash Flow to Operating Cash Flow
 0.85 0.84 0.72 0.76 -4.22
Dividend Paid and CapEx Coverage Ratio
 5.50 3.33 2.37 2.77 0.14
Capital Expenditure Coverage Ratio
 6.60 4.23 3.57 4.13 0.19
Operating Cash Flow Coverage Ratio
 4.57 6.07 3.14 4.82 0.11
Operating Cash Flow to Sales Ratio
 0.26 0.38 0.30 0.31 0.02
Free Cash Flow Yield
5.11%9.90%4.99%6.26%-1.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.70 7.65 12.59 14.38 81.13
Price-to-Sales (P/S) Ratio
 4.33 3.25 4.37 3.80 7.09
Price-to-Book (P/B) Ratio
 2.29 1.90 2.99 2.11 3.23
Price-to-Free Cash Flow (P/FCF) Ratio
 19.58 10.10 20.04 15.98 -70.30
Price-to-Operating Cash Flow Ratio
 16.61 8.50 14.43 12.11 296.61
Price-to-Earnings Growth (PEG) Ratio
 10.59 0.21 0.13 0.04 -1.32
Price-to-Fair Value
 2.29 1.90 2.99 2.11 3.23
Enterprise Value Multiple
 9.83 5.84 10.16 10.68 54.28
Enterprise Value
 199.35B 125.22B 177.94B 103.29B 141.13B
EV to EBITDA
 9.83 5.84 10.16 10.68 54.28
EV to Sales
 4.37 2.83 4.45 3.81 7.25
EV to Free Cash Flow
 19.73 8.77 20.40 16.05 -71.93
EV to Operating Cash Flow
 16.74 7.38 14.69 12.16 303.51
Tangible Book Value Per Share
 468.73 410.13 315.31 490.21 226.46
Shareholders’ Equity Per Share
 483.02 424.69 326.07 266.96 233.75
Tax and Other Ratios
Effective Tax Rate
 0.17 0.18 0.17 0.17 0.16
Revenue Per Share
 254.78 247.43 222.95 148.36 106.70
Net Income Per Share
 86.96 105.26 77.34 39.18 9.32
Tax Burden
 0.84 0.82 0.83 0.83 0.84
Interest Burden
 1.01 1.17 1.07 1.06 1.64
Research & Development to Revenue
 0.02 0.02 0.03 0.03 0.09
SG&A to Revenue
 0.04 0.14 0.00 0.00 0.24
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 0.59 0.90 0.87 0.99 0.23
Currency in INR